MEDBOX | Category Leprosy

Leprosy

Advanced search

Create your MEDBOX

Leprosy

Advanced search

Create your MEDBOX

Go back

OUR RECOMMENDATIONS

How to Recognise and Manage Leprosy Reactions (2002)

How To Prevent Disability In Leprosy Part 1 (2001)

Leprosy For Medical Practitioners and Paramedical Workers (2009)

Guidelines for the Diagnosis, Treatment and Prevention of Leprosy (2018)

A guide for surveillance of antimicrobial resistance in leprosy: 2017 update (2017)

NEW

NEW

Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)

Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)

Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis (2020)

Safety in administering medicines for neglected tropical diseases (2021)

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

20 records

	Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease PAHO PAHO, WHO (2021) CC View PDF(75) Download (47) Add to my MEDBOX In 2016, PAHO's Directing Council, through Resolution CD55.R9, approved the “Plan of Action for Elimination of Neglected Infectious Diseases (NID) and Post-Elimination Actions, 2016-2022.” This Resolution urges Member States to implement a set of interventions to reduce the burden of disease by NID in the Americas by 2022, including “…support promotion of treatment, rehabilitation, and related support services through an approach focused on integrated morbidity management and disability prevention for individuals and families afflicted by those neglected infectious diseases that cause disability and generate stigma.” NIDs can have devastating chronic sequelae for patients, such as disability, visible change or loss in body structure, loss of tissue, and impairment of proper tissue and organ function, among others. All of these can in turn lead to unjustified discrimination, stigmatization, mental health problems, and partial or total incapacity to work, perpetuating the vicious cycle of neglected diseases as both a consequence and a cause of poverty. Patients with chronic conditions caused by NIDs require proper health care in order to prevent further damage and improve their living and social conditions. This should be provided at the primary health care level, as patients suffering from NIDs are often unable to travel to or afford to pay for specialized care services. Care for patients suffering from chronic morbidity caused by NID should be integrated into care for other chronic conditions caused by non-communicable diseases. This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful Tags: Guidelines, care and prevention, Chagas, Lymphatic filariasis, Leprosy, Trachoma, Source: https://iris.paho.org/handle/10665.2/533
	Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease Pan American Health Organisation PAHO (2021) C_WHO View PDF(158) Download (166) Add to my MEDBOX This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be used mainly by health care workers at the primary health care level, but health workers at more complex and specialized levels may also find it useful Tags: Leprosy, Lymphatic filariasis, Chagas, Trachoma, Neglected Tropical Diseases (NTDs), care, health-care workers, primary health care, Source: https://iris.paho.org/bitstream/handle/1
	The Diagnosis of leprosy slide sets S.Noto; P.A.M.Schreuder and B. Naafs (2011) CC View PDF(3774) Download (2562) Add to my MEDBOX slides Tags: Communicable diseases, Source: https://medbox.org/dl/5e148832db60a2044c
	Safety in administering medicines for neglected tropical diseases World Health Organization WHO (2021) C_WHO View PDF(190) Download (234) Add to my MEDBOX This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjunction with the accompanying training modules, which provide practical instruction, and the aide-mémoires. Versions of the aide-mémoires and training modules are available respectively for both (i) programme managers and district-level health officials and (ii) community drug distributors and community health worker Tags: NTD, neglected tropical diseases, Essential Medicine, job aid, Training, practical instructions, programme managers, health professionals, chemotherapy, mass drug, Community Health Worker (CHW), Source: https://apps.who.int/iris/rest/bitstream
	Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis World Health Organization WHO (2020) C_WHO View PDF(159) Download (135) Add to my MEDBOX This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, administration of prophylactic drugs. Managerial aspects to undertake contact screeninig and chemoprophylaxis are also elaborated, including planning , training , supervision and drug management Tags: Leprosy, leprosy control, leprosy treatment, chemoprophylaxis, rifampicin, Surveillance, Contact Tracing, Screening, Source: https://apps.who.int/iris/rest/bitstream
	International Textbook of Leprosy D.M. Scollard and T.P. Gillis American Leprosy Missions (2018) C1 Open external link (2620) Add to my MEDBOX The International Textbook of Leprosy is dedicated to the physicians and health workers caring for their first patient with leprosy, and to all of those in the research community who have encountered some of the fascinating scientific aspects of leprosy and wish to learn more. Read online at: http://www.internationaltextbookofleprosy.org Tags: Leprosy, leprosy treatment, leprosy control, Clinical Guidelines, stigma reduction, stigma, diagnosis, Source: https://www.internationaltextbookoflepro
	Guidelines for the Diagnosis, Treatment and Prevention of Leprosy World Health Organization WHO (2018) C_WHO View PDF(925) Download (389) Add to my MEDBOX The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (‎especially but not limited to endemic countries)‎, nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected person Tags: Guidelines, leprosy control, leprosy treatment, chemoprophylaxis, diagnosis, Source: https://apps.who.int/iris/handle/10665/2
	A guide for surveillance of antimicrobial resistance in leprosy: 2017 update E. A. Cooreman WHO SEARO/Department of Control of Neglected Tropical Diseases (2017) C_WHO View PDF(1475) Download (471) Add to my MEDBOX In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of infections. Clofazimine resistance is still rare but this antimicrobial cannot be given alon Tags: AMR, antimicrobial, Antimicrobial resistance, Leprosy, Source: https://apps.who.int/iris/bitstream/1066
	Diagnosis and the clinical spectrum of leprosy Salvatore Noto, Pieter A. Schreuder and Bernard Naafs ILEP (2011) C2 View PDF(4304) Download (1346) Add to my MEDBOX Tags: Laboratory diagnostics, Source: http://www.ilep.org.uk/fileadmin/uploads
	Leprosy For Medical Practitioners and Paramedical Workers Yawalker, S. (2009) C1 View PDF(4837) Download (6047) Add to my MEDBOX Tags: Clinical Guidelines, neglected tropical diseases, NTD, Treatment, Source: http://www.novartisfoundation.org/mandan

20 records

20 records